To define the syndrome of vasovagal reactions that occur during colono
scopy and to identify those risk factors associated with this developm
ent, we prospectively evaluated patients undergoing colonoscopy with m
onitored sedation. A total of 223 consecutive patients were evaluated
during the 60-day study period. A vasovagal reaction was defined as th
e occurrence of one or more of the following: diaphoresis, sustained b
radycardia of less than 60 beats/min or a decrease in heart rate of 10
%, or hypotension (systolic blood pressure less than 90 mm Hg, diastol
ic blood pressure less than 60 mm Hg, or a reduction in blood pressure
of more than 10% below a baseline measurement before colonoscopy and
after sedation). Thirty-seven (16.5%) of the 223 patients experienced
a vasovagal reaction by our criteria. The remaining 186 patients did n
ot; 100 of these patients were randomly selected by computer to form a
control group. No statistically significant differences were observed
between the vasovagal and control groups with regard to demographics,
cardiopulmonary disease, cardiac medications, procedure success, the
endoscopist, patient procedure tolerance, colon preparation, or proced
ure difficulty. A significant difference was seen in the mean dose of
midazolam used in the vasovagal group as compared with that used in th
e control group (4.6 mg versus 3.9 mg, p < 0.04), and moderate to seve
re diverticulosis was more commonly seen in the vasovagal group as com
pared with the control group (43% versus 16%, p < 0.02). Thirteen (35%
) of the 37 patients who had a vasovagal reaction required medical int
ervention (5.8% of the 223 patients). No interventions were required i
n control patients. Vasovagal reactions during colonoscopy are commonl
y detected if careful procedure monitoring is performed. However, the
need for medical intervention during the vasovagal reaction is uncommo
n, and in our patients, no significant post-procedural sequelae occurr
ed.